Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.49M Buy
41,200
+25,000
+154% +$2.83M 1.79% 13
2026
Q1
$1.8M Buy
16,200
+15,960
+6,650% +$1.89M 0.63% 14
2025
Q4
$192K Buy
+240
New +$26.2K 0.09% 12

Other funds holding ABVX

PSquared Asset Management's ABVX Position: Q2 2026 in Review

PSquared Asset Management increased its Abivax (ABVX) stake by 154% in Q2 2026, buying an estimated $2.83M and bringing the position to 41,200 shares worth $5.49M. The position accounts for 1.79% of the portfolio, ranked #13.

PSquared Asset Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • PSquared Asset Management held 41,200 shares of Abivax worth $5.49M as of Q2 2026.
  • PSquared Asset Management bought 25,000 Abivax shares in Q2 2026, an estimated $2.83M.
  • Abivax made up 1.79% of PSquared Asset Management's portfolio in Q2 2026, its #13 holding.
  • PSquared Asset Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on PSquared Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.